Page last updated: 2024-10-16

betaine and Retinopathy of Prematurity

betaine has been researched along with Retinopathy of Prematurity in 1 studies

glycine betaine : The amino acid betaine derived from glycine.

Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Betaine was intravitreally injected in OIR mice at postnatal day (P) 14."5.46Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. ( Jun, HO; Kang, BC; Kim, JH; Kwon, E; Park, SW; Park, YJ; Yun, JW, 2017)
"Betaine was intravitreally injected in OIR mice at postnatal day (P) 14."1.46Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. ( Jun, HO; Kang, BC; Kim, JH; Kwon, E; Park, SW; Park, YJ; Yun, JW, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, SW1
Jun, HO1
Kwon, E1
Yun, JW1
Kim, JH2
Park, YJ1
Kang, BC1

Other Studies

1 other study available for betaine and Retinopathy of Prematurity

ArticleYear
Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Vascular pharmacology, 2017, Volume: 90

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Astrocytes; Betaine; Cell Movement; Cell Prolife

2017